bluebird bio Statement on European Regulatory Status of LentiGlobin™ Read more about bluebird bio Statement on European Regulatory Status of LentiGlobin™
bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina Read more about bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina
Cowen and Company 39th Annual Health Care Conference Read more about Cowen and Company 39th Annual Health Care Conference
bluebird bio to Present at Investor Conferences in March Read more about bluebird bio to Present at Investor Conferences in March
bluebird bio Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress Read more about bluebird bio Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress
bluebird bio Appoints Chip Baird as Chief Financial Officer Read more about bluebird bio Appoints Chip Baird as Chief Financial Officer
bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies Read more about bluebird bio and Inhibrx Announce Collaboration to Research, Develop and Commercialize CAR T Cell Immunotherapies
bluebird bio to Present at the 37th Annual J.P. Morgan Healthcare Conference Read more about bluebird bio to Present at the 37th Annual J.P. Morgan Healthcare Conference